Abstract
Infection with Helicobacter pylori poses a threat to public health in numerous regions of the world. This bacterium has been linked to a wide range of stomach disorders, some of which are benign, such as superficial gastritis, while others are rather serious, including chronic atrophic gastritis, stomach cancer, and peptic (gastric or duodenal) ulcers. These conditions can vary in severity and cause significant morbidity in the affected individual. The International Agency for Research on Cancer designated it as a ‘Group I carcinogen’ in the year 1994 after concluding that it played a significant role in the development of stomach cancer. As a result, there has been a considerable focus on discovering ways to prevent H. pylori infections. In this article, we discuss the role that H. pylori plays in human gastric disease, with a particular focus on the impact of dietary agents on preventing infection and on the pathogenesis of H. pylori. © 2024 Bentham Science Publishers. All rights reserved.
Keyword: Campylobacter pyloridis, Dietary agents, Gastric cancer, Helicobacter pylori, Medicine.
Metabolites of Medicinal Plants: Insightful Approaches